{"id":"W4414042050","doi":"10.1016/j.esmoop.2025.105576","title":"Phase I dose-escalation trial of AMXT 1501 dicaprate plus difluoromethylornithine: a dual-agent approach targeting immunosuppressive polyamine metabolism","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Nexen (Canada)","funders":"Aminex Therapeutics","keywords":"Metabolism; Phase (matter); Immune system; Enzyme; Polyamine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001004143,0.001606143,0.001725719,0.0005677644,0.0003283964,0.0007856925,0.0008929312,0.001088597,0.002442427],"category_scores_gemma":[0.0005548687,0.0005100775,0.000705656,0.0003792191,0.0007654199,0.0006870735,0.0004022106,0.002483306,0.0005871959],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008545629,"about_ca_system_score_gemma":0.001284712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006268537,"about_ca_topic_score_gemma":0.001316363,"domain_scores_codex":[0.9996659,0.0001239686,0.00001871468,0.00007020164,0.00003568747,0.00008567563],"domain_scores_gemma":[0.9995084,0.00006531322,0.0001175386,0.00005872282,0.00003295148,0.0002171097],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5446918,0.1374513,0.006572132,0.0008000568,0.0009877998,0.0003225987,0.0004107714,0.004875313,0.1894027,0.0005956091,0.003807621,0.1100823],"study_design_scores_gemma":[0.2941728,0.6801386,0.008365056,0.00002701969,0.0003114719,0.0002528822,0.00004930509,0.001822883,0.01222687,0.0001656913,0.002435472,0.00003197201],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957371,0.0006319488,0.0003226745,0.0001545982,0.00005253984,0.001782545,0.0003850056,0.00006488838,0.0008686682],"genre_scores_gemma":[0.992018,0.0006369421,0.001721787,0.0004375669,0.0001093063,0.002208707,0.001032913,0.00001813187,0.001816518],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002442427,"threshold_uncertainty_score":0.008170724,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01630794989620173,"score_gpt":0.3240945966316325,"score_spread":0.3077866467354308,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}